Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Contemp Clin Trials. 2020 Apr 17;93:106007. doi: 10.1016/j.cct.2020.106007

Table 2.

Secondary clinical outcomes: Guideline-Concordant Care Quality Measures

Treatment Domain CoC* Criteria for Quality Cancer Care
Radiation Radiation therapy administered within 365 days of diagnosis for women < 70 years receiving breast conserving surgery
Radiation therapy administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with ≥ 4 positive regional lymph nodes
Chemotherapy Combination chemotherapy administered within 120 days of diagnosis for women <70 with AJCC T1c N0 M0, or Stage II or III Estrogen Receptor and Progesterone Receptor (ER and PR) negative breast cancer
Hormonal Tamoxifen or aromatase inhibitor administered within 365 days of diagnosis for women with AJCC T1c N0 M0, or Stage II or III ER and/or PR+ breast cancer.